#00372
Scientific risk, weak commercial returns and unequal market access leave too few innovative antibiotics for priority resistant pathogens and limit delivery after approval.
Coming soon...
We aim to provide a platform where you can support issues through funding.
This will allow you to contribute financially to causes you care about, helping to drive change and support initiatives that matter to you.
Non-profit organizations, community projects and for-profit initiatives will be able to receive funding from individuals and organizations based on certain conditions.